The study of tissue-derived Mycobacterium leprae provides insights to the immunopathology of leprosy and helps identify broad molecular features necessary for mycobacterial parasitism. A major membrane protein (MMP-II) of in vivo-derived M. teprae previously recognized (Hunter, S.W., B. Rivoire, V. Mehra, B.R. Bloom, and P.J. Brennan. 1990. J. Biol. Chem. 265:14065) was purified from extracts of the organism and partial amino acid sequence obtained. This information allowed recognition, within one of the cosmids that encompass the entire M. leprae genome, of a complete gene, bfr, encoding a protein of subunit size 18.2 kD. The amino acid sequence deduced from the major membrane protein II (MMP-II) gene revealed considerable homology to several bacterioferritins. Analysis of the native protein demonstrated the iron content, absorption spectrum, and large native molecular mass (380 kD) of several known bacterioferritins. "][prosy is a chronic disease of the skin and nerves caused by Mycobacterium leprae. Chemotherapy is successful but requires protracted multidrug therapy and the continuing evolution of new drug regimens. The world-wide prevalence of leprosy is now estimated at less than 5 million cases compared with 10-12 million in the mid-1980s (1). Much of this decline is attributed to chemotherapy. Nevertheless, leprosy still represents a major public health problem within regions of Latin America, Africa, and Asia, many of them not amenable to the standard drug regimens. Hence, the development of a vaccine that could contribute to the eradication of the disease remains a goal of some leprosy research programs.
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The molecular definition of M. leprae is fundamental to an understanding of the physiology and metabolism of the bacillus and the immunoregulatory mechanisms underlying the disease and protection against it. The leprosy bacillus grows intracellularly in cells of the reticuloendothelial system and Schwann cells, and it is so well adapted to this habitat that it has evaded axenic cultivation so far (2) . The development of the armadillo as a relatively rich source of the bacillus has allowed extensive study of the physiology of the organism (2) and definition of the chemistry of the highly antigenic glycoconjugates and their roles in pathogenesis (3) . Screening of M. leprae genomic libraries with antibodies has also permitted the isolation of genes that encode protein antigens, many of which are related to components of the highly conserved family of stress proteins (4) .
A landmark in leprosy research that may revolutionize our knowledge of the basis of the obligate parasitism ofM. leprae is the recently initiated "M. leprae genome project" (5). Present achievements from this undertaking include an ordered collection of overlapping clones encompassing the complete chromosome of M. leprae in which 72 loci have been mapped (5) and the complete sequence of 27 cosmids representing approximately one third of the genome (6; Smith, D.R., unpublished data). In an attempt to complement this genetic approach, we initiated a program to identify and characterize the major proteins expressed in vivo by the leprosy bacillus. The dominant proteins from the different subcellular fractions ofM. leprae were identified in terms of relative size and antibody-binding patterns, and some of these were immediately recognized as the previously described stress proteins (7) . However, two major novel proteins were identified and designated major membrane protein I (MMP-I) 1 and major membrane protein II (MMP-II). The present study describes the purification, biochemical characterization and gene sequence of MMP-II, pointing to a novel '~380-kD bacterioferritin (Bfr), an iron-rich protein that probably plays a crucial role in the intracellular existence of M. leprae.
Materials and Methods
Purification of MMP-II. M. leprae was purified from irradiated armadillo spleens and livers by the Draper protocol as described previously (8) . Frozen bacteria (300 rag, dry weight) were resuspended in 3 ml of PBS containing 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mM benzamidine and disrupted by intermittent probe sonication (W-385 sonicator; Heat SystemsUltrasonics, Inc., Farmingdale, NY) for four 15-rain periods on ice. The suspension was centrifuged at 27,000g for 30 rain to remove unbroken cells and cell walls. The supernatant was further centrifuged at 100,000g for 2 h to remove membranes and polysomes. Mycobacterial lipoglycans (lipoarabinomannan, lipomannan, and phosphatidylinositol mannosides) were removed from the resulting supernatant by fractionation on DEAE-Sephacd (Pharmacia Biotech, Inc., Piscataway, NJ) equilibrated in 20 mM piperazine buffer, pH 5.7. After washing the column with 160 mM LiC104, proteins were duted with 1 M salt and subjected to gd filtration on a Sephacryl S-200 (Pharmacia Biotech, Inc.) column (1 x 120 cm) equilibrated with PBS. MMP-II in the eluates was monitored by SDS-PAGE. The fractions containing MMP-II were combined, dialyzed against water and concentrated. Further purification of MMP-II was accomplished on a reversed phase HPLC column (model C4; 0.46 x 25 cm; VYDAC, Hesperia, CA). Proteins were eluted from the column at a flow rate of 1 ml/min using a linear gradient from 70% solvent A (trifluoroacetic acid/water, 0.1:99.9), 30% solvent B (trifluoroacetic acid/water/acetonitrile, 0.1:9.9:90) to 30% solvent A/70% solvent B over 40 rain. The final highly purified MMP-II was obtained upon elution with a linear gradient from 70 to 100% solvent B in 30 min. The multimeric form of MMP-II was obtained by affanity chromatography based on the monoclonal antibody CS-41 (7). CS-41 was purified from ascites fluid by protein G agarose column chromatography (Schleicher & SchueU, Inc., Keene, NH). A 1-ml affinity column was constructed by using the Afl~nica antibody orientation kit (Schleicher & Schuell, Inc.) as recommended by the manufacturer. The column was equilibrated with PBS, the soluble fraction of the bacteria applied and nonspecifically bound proteins were removed with 1 M NaC1 after washing the column with PBS. MMP-II was eluted with 1 M ammonium hydroxide, pH 11.5. Fractions were immediately neutralized with 1 M HC1 and dialyzed against 10 mM Tris-HC1, pH 7.5 Amino Acid Sequence of MMP-II. The pure protein was reduced with B-mercaptoethanol and subsequently alkylated with 4-vinylpyridine. The sample was desalted on a Vydac C4 reversed-phase HPLC column (0.46 by 5 cm) under the conditions described above. Fractions were pooled, dried, and treated with each of the following enzymes: endoproteinase Lys-C (from Lysobacter enzymogenes) (Boehringer Mannheim Corp., Indianapolis, IN), trypsin (treated with tolylsulfonyl phenylahnyl chloromethyl ketone) (Sigma Chem1Abbreviations used in this paper: Bfr, bacterioferritin; MMP-I, major membrane protein I; MMP-II, major membrane protein II; SSC, sodium chloride-sodium citrate.
ical Co., St. Louis, MO), and endoproteinase Asp-N (from Pseudo. monasfragi) (Boehringer Mannheim Corp.) . Before use, the trypsin was repurified by reversed phase HPLC (9) . Digestions were accomplished on samples of 200-300 pmol as described by Lee and Shively (10) . The enzyme/protein ratios were typically 1:50. Peptide mapping was performed using a capillary HPLC system as described by Davis and Lee (11) , equipped with a 0.5-mm microcolumn packed with VYDAC C18 resin. The peptides were eluted at a flow rate of 0.02 ml/min using a linear gradient from 100% solvent A (trifluoroacetic acid/water, 0.1:99.9) to 40% solvent A/60% solvent B (trifluoroacetic acid/water/acetonitrile, 0.1:9.9:90) in 60 min.
Absorbance at 214 nm was monitored with a SPD-6A UWVIS monitor equipped with a microanalytical flow cell (Shimadzu Corp., Tokyo, Japan). Peptides were spotted on polyvinylidene difluoride membranes (Millipore Corp., Bedford, MA) and subjected to automated Edman degradation on a gas-phase sequencer built at City of Hope (12) and equipped with a continuous-flow reactor (13) . The phenylthiohydantoin amino acid derivatives were indicated by on-line reversed-phase HPLC. Sequences were confirmed by fast atom bombardment-mass spectrometry as described (14) . M. leprae Genome Sequencing and Sequence Analysis. The construction of a physical genetic map of the M. leprae genome has been described (5). Multiplex sequencing of cosmid B38 was conducted as described by Church and Kieffer-Higgins (16) and will be described in detail elsewhere. The application of multisequence analysis using the program PILEUP from Genetic Computer Grouping (GCG, Wisconsin Package) has been described (17) . The hydropathy plot of the predicted amino acid sequence was constructed by the method of Kyte and Doolittle (18) .
PCR Amplification of the MMP-II
Southern Hybridization. Genomic DNA from M. leprae was purified as described (19) . Purification of armadillo genomic DNA from uninfected liver and other standard DNA manipulation techniques were performed according to Maniatis et al. (15) . 3-5/zg of purified DNA were digested with restriction enzymes and fractionated in 0.8% agarose gel electrophoresis. The 0.33-kb PCR product was labeled with digoxigenin by primer extension with random hexamers (Boehringer Mannheim Corp.). Hybridization was conducted at 42~ for 16 h in buffer containing five times the concentration of standard sodium chloride-sodium citrate (SSC) (1 x SSC is 0.15 M NaC1 plus 0.015 M sodium citrate), 0.1% N-lauroylsarcosine, 0.02% SDS, 5% (wt/vol) blocking reagent for nucleic acid hybridization (Boehringer Mannheim Corp.), and 50% formamide (vol/vol). The blots were washed twice for 5 rain at room temperature in 2 x SSC with 0.1% SDS. Stringent washes were performed twice for 15 min at 65~ or 40~ in 0.1 x SSC containing 0.1% SDS. Chemiluminescent detection with LumiPhos 530 was conducted following the manufacturer recommendations (Boehringer Mannheim Corp.). Membranes were exposed to XAR-2X-RAY film (Eastman Kodak Co., Rochester, NY).
Physical and Chemical Assays. Visible-and UV-absorption spectra of the purified protein were obtained with a Varian Cary 118-C double-beam spectrophotometer (Varian Instrument Business, San Fernando, CA) in 1-cm pathlength microcuvettes. Absorption maxima of the reduced product were obtained after mixing in a few crystals of sodium dithionite. The iron content of the purified protein was determined by inductively coupled plasma-optical emission spectroscopy on an atomcomp (model 975; Thermo Jarrell Ash, Franklin, MA). The iron content was related to protein content as estimated by amino acid analysis in a Beckmen High Performance Amino Acid Analyzer System (Model 6300; Beckman Instruments Inc., FuUerton, CA) after the sample had been hydrolyzed with 6 M HC1 for 24 h at 110~ Molecular mass estimation was performed by gel filtration on Superose 6 fast performance liquid chromatography (FPLC) and Sephacryl S-300 columns (Pharmacia Biotech, Inc.). Columns were equilibrated with 10 mM Tris-HC1 pH 7.5 containing 0.15 M NaC1 and calibrated using four standard proteins: aldolase (150 kD), catalase (232 kD), ferritin (440 kD), and thyroglobulin (669 kD) (Pharmacia LKB). SDS-PAGE was per- Figure 1 . Purification of MMPolI. Silver-stained SDS-PAGE of purified protein after elution from C4 reversed-phase column. Molecular mass standards are indicated on the left side.
formed on uniform 15% gels or 4-20% gradient gels according to Laemmli (20) and proteins were stained with silver nitrate or Coomassie blue.
Results

Amino Acid Sequence of MMP-II. MMP-II was initially
identified as a major band of 22 kD by SDS-PAGE analysis of the membrane fraction of leprosy bacillus (7). However, after disrupting the cells with prolonged sonic oscillation, considerable quantities of MMP-II were present in the soluble fraction of the bacteria. The protein was purified from this source by conventional chromatography (Fig. 1) . Most of the lipoarabinomannan, lipomannan, and phosphatidylinositol mannosides were successfully removed by passing the soluble fraction through DEAE-Sephacryl. Further fractionation of the soluble proteins was achieved by Sephacryl S-200 gel filtration chromatography from which MMP-II was eluted close to the void volume. Rechromatography of the MMP-II-conraining fractions on a C4 reversed-phase HPLC column provided highly purified protein (Fig. 1) . From 300 mg (dry weight) of M. leprae, 14 mg of soluble protein were recovered of which 50 ktg were pure MMP-II. Amino acid sequencing of MMP-II involved digestion with three different endoproteinases: trypsin, Lys-C, and Asp-N. Table 1 shows the list of peptides whose sequences were confirmed by mass analysis. In one instance, KS, the sequence data were incomplete; however, the correct assignment was achieved by overlapping the sequence with T23 and from the mass data. The NH2-terminal sequence as obtained on this occasion was different in position 2 from that reported previously (7) and is now in accord with the gene sequence (see below).
Amplification of the MMP-II Gene by PCR. Oligonucleotides with low degeneracy were derived from the amino acid sequence and three alternative reactions were run. The PCR products were analyzed by electrophoresis on agarose gel ( (Fig. 4) . In addition, prediction of MMP-II secondary structure employing the Peptide Structure Program (GCG Wisconsin Package) indicated a high (*80%) c~-helix content, consistent with the presence of the ferritin-like four-helix bundle characteristic of other Bfrs (21, 26) . The hydropathy plot (not shown) of the deduced protein sequence conducted as described (18) showed the occurrence of only a few short stretches of hydrophobic amino acids consistent with a soluble/peripheral membrane protein.
At the nucleic acid level, the sequence contains a ribosome binding site with significant homology to the 3' end of the M. leprae 16S rRNA (27) preceding a methionine start codon at nucleotide 630 in Fig. 3 . A sequence with significant homology to an iron box (28), but without any dyad symmetry, occurs in an AT-rich region surrounding nucleotide 540 which may correspond to the transcriptional initiation site of the gene. Several regions of dyad symmetry were noted in the sequence, including one centered at nucleotide 177 upstream of the gene and at nucleotide 1077 near the translation termination site.
Biochemical Characterization of M. leprae Bfr. Crystallographic studies (29) and electron microscopic imaging (23) demonstrate that Bfrs share similar quaternary structure to ferritins. Ferritins are multimeric proteins that contain 24 identical subunits forming a spherical shell enclosing a central cavity that contains up to ~4,500 Fe(III) atoms of nonhaem iron (30) . However, Bfrs differ from ferritins in that they are haem proteins containing protoporphyrin IX as prosthetic group (31) (32) (33) . To establish whether the M. leprae
Bfr also shared some of these characteristics, chemical analyses were conducted on the native protein. Small quantities of the pure protein were obtained in the native form by affinity chromatography based on the monoclonal antibody GS-41. 
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Pessolani et al. Fig. 5, lane 2) , close in size to ferritin (440 kD) (Fig. 5, lane I) . By heating the sample before loading on the gel, the multimer dissociated into subunits of approximate molecular mass 20 kD (Fig. 5, lane 3) . Fig. 5 , lane 4 shows the subunit form as obtained after reversed-phase chromatography (Fig. 1) . The molecular mass of the multi- 
Discussion
Iron is essential to the growth of all living ceils; it is required for the transport and storage of oxygen, and as a catalyst in electron transport processes (34) . In an aerobic atmosphere, however, iron is extremely insoluble and available in limited amounts. Organisms have therefore developed mechanisms for solubilizing iron and, in many cases, for storing it within particular molecules. Animals have solved the problem of iron acquisition by using ferritin as a ubiquitous iron storage compound and transferrin and lactoferrin for movement of iron (35) . Little or no free iron then exists within animal bodies and pathogenic bacteria must acquire iron from such sources. Iron metabolism is therefore considered to play a central role in virulence, and a mechanism to scavenge iron is a requisite for microbial pathogenicity (36) . In this context, the observation that one of the most abundant proteins present in in vivo grown M. leprae is a Bfr, a protein involved in ferrometabolism, must be of considerable significance.
This present development was due to our technical ability to isolate, even from scarce tissue-derived M. leprae, sufficient amounts of this major protein to obtain partial amino acid sequence, to estimate the size and iron content, and, through absorption spectroscopy, establish other relationships to known M. leprae genes have been identified, and, in many cases, precise functions can be attributed on the basis of extensive sequence homology. However, the present work, in that it defines a protein that corresponds to a gene identified in this fashion, extends the implications of the research beyond the level of comparisons with known gene sequences. Clearly, the derived amino acid sequence from the MMP-II gene showed significant homology with Bfrs already described in the literature (Fig. 4) , and it also shared 100% identity with the first 42 amino acids of antigen D, a Bfr isolated from M. paratuberculosis (23, 37) . Bfrs are haem proteins, and the optical spectrum of reduced MMP-II showed o~, 3, and Soret bands at 557, 523, and 422 nm, respectively, demonstrating the presence of protoporphyrin IX as a prosthetic group. Recently, a bis-methionine axial ligation of haem has been demonstrated in Bfr from Pseudomonas aeroginosa (38) , and, based on this information, alternative models involving two conserved methionine residues have been postulated as providing the haem ligands in other Bfrs (21, 26) . With the inclusion of the M. leprae Bfr, it can be seen that only the methionine at position one remains conserved among the sequences of all Bfrs (Fig. 4) . These results open up new questions about the haem binding site in Bfrs. Fig. 4 (39) . Among these mycobacteria, the M. paratuberculosis Bfr shared the highest homology with M. leprae Bfr (Fig. 8) . Interestingly, in terms of iron acquisition, both M. leprae and M. paratuberculosis behave similarly. During the early stages of growth after isolation from the host, M. paratuberculosis demonstrates an obligate need for exogenous mycobactins, exochelins or an excess of citric ferric (40) . Thus, the similarity between the Bfrs ofM. leprae and M. paratuberculosis raises the possibility that both acquire iron in vivo through a similar mechanism in which Bfr plays a central role, thereby imposing high conservation on the primary sequences.
The function of Bfrs is still unclear. Based on their structural similarity to ferritins, it has been proposed that Bfrs are involved in the safe storage of iron in iron-overloading conditions. However, Bfrs differ from their eukaryote analogs in two major respects which may be indicative of unique functions for Bfrs. First, they contain haem residues with properties similar to those of b-type cytochromes. Indeed, E. coli and A. vinelandii Bfrs were first isolated as cytochrome bl and bss7.s, respectively, and a role for these in electron transport systems has been proposed (24, 31, 41) . The interaction between haem components and the ability of Bfrs to store nonhaem iron is, however, not understood. Second, in contrast to plants and animals in which ferritin synthesis is induced by iron (30), the Bfrs subunits retain a constant concentration regardless of the iron status of the cell (25) . Also, in iron-deficient cyanobacterium Synechocystes, Bfrs seem to play a role as intermediates in iron acquisition, acting as a temporary depository (25) . However, in overloaded cells, Bfr iron represents a very low proportion of the total iron content, and low molecular mass molecules carry the bulk of the cellular iron content and fulfill the iron storage function. These results are supported by studies performed on E. coli in which Bfr iron was shown to represent no more than 1% of the total cellular iron, the bulk of iron in the iron-rich cells being in the form of aggregates (42, 43) .
The mechanism adopted by M. leprae to acquire iron inside macrophages is unknown. Macrophages are one of the major iron storage cells of the human body, and most iron is found as ferritin in the cytosol and as hemosiderin inside lysosomal membranes (35) . Two major mechanisms by which bacteria remove iron from host compounds have been described. Microbes such as the pathogenic Neisseria spp., possess iron acquisition systems using surface receptors for host Febinding proteins (28) . However, in most mycobacteria, iron acquisition mechanisms involve two different types of siderophores, the extracellular exochelins and the cell-bound mycobactins (44) . Also, a set of iron-regulated envelope proteins has been implicated as exochelins receptors (45) . In 
